Skip to main content
. 2023 Feb 3;2023:7035893. doi: 10.1155/2023/7035893

Table 4.

Relationship between adherence status and side effects experienced.

Side effect experienced n (%) Adherence, 113 (83.7) Nonadherence, 22 (16.3) p value
Loss of energy drive
 No 46 (34.1) 32 (69.6) 14 (30.4) 0.001
 Yes 89 (65.9) 81 (91.0) 8 (9.0)
Feeling unmotivated
 No 68 (50.4) 53 (77.9) 15 (22.1) 0.068
 Yes 67 (49.6) 60 (89.5) 7 (10.5)
Day time sedation
 No 59 (43.7) 47 (79.7) 12 (20.3) 0.262
 Yes 76 (56.3) 66 (86.8) 10 (12.2)
Too much sleep
 No 75 (55.6) 62 (82.7) 13 (17.3) 0.715
 Yes 60 (44.4) 51 (85.0) 9 (15.0)
Muscle too stiff
 No 100 (74.1) 85 (85.0) 15 (15.0) 0.491
 Yes 35 (25.9) 28 (80.0) 7 (20.0)
Shaking
 No 86 (63.7) 70 (81.4) 16 (18.6) 0.336
 Yes 49 (36.3) 43 (87.8) 6 (12.2)
Jittery
 No 94 (69.6) 77 (81.9) 17 (18.1) 0.394
 Yes 41 (30.4) 36 (87.8) 5 (12.2)
Akathisia
 No 104 (77.0) 85 (81.7) 19 (18.3) 0.256
 Yes 31 (23.0) 28 (90.3) 3 (9.7)
Trouble waking up
 No 66 (48.9) 55 (83.3) 11 (16.7) 0.909
 Yes 69 (51.1) 58 (84.1) 11 (15.9)
Vision changes
 No 96 (71.1) 78 (81.2) 18 (18.8) 0.226
 Yes 39 (28.9) 35 (89.7) 4 (10.3)
Dry mouth
 No 89 (65.9) 74 (83.1) 15 (16.9) 0.807
 Yes 46 (34.1) 39 (84.8) 7 (15.2)
Drooling of saliva
 No 115 (85.2) 96 (83.5) 19 (16.5) 0.865
 Yes 20 (14.8) 17 (85.0) 3 (15.0)
Memory problems
 No 72 (53.3) 60 (83.3) 12 (16.7) 0.901
 Yes 63 (46.7) 53 (84.1) 10 (15.9)
Constipation
 No 99 (73.3) 85 (85.9) 14 (14.1) 0.261
 Yes 36 (26.7) 28 (77.8) 8 (22.2)
Weight changes
 Decrease 24 (17.8) 22 (91.7) 2 (8.3) 0.294
 Increase 77 (57.0) 65 (84.4) 12 (15.6)
 No change 34 (25.2) 26 (76.5) 8 (23.53)
Sexual arousal
 No 63 (46.7) 53 (84.1) 10 (15.9) 0.901
 Yes 72 (53.3) 60 (83.3) 12 (16.7)
Menstrual changes
 No 113 (83.7) 97 (85.8) 16 (14.2) 0.128
 Yes 22 (16.3) 16 (72.7) 6 (27.3)
Total number of side effects experienced (mean, SD) 6.8 (±3.0) 7.0 (±2.9) 5.9 (±3.3) 0.136